Home Page
Welcome
Committees
Scientific Program
Timetable
Acknowledgements
Registration
General Information
Accompanying Persons
Accommodation
& Tours
Optional Congress Tours & Transfers
 

 

 

SUNDAY,
SEPTEMBER 29, 2002
MONDAY,
SEPTEMBER 30, 2002
TUESDAY,
OCTOBER 1, 2002
WEDNESDAY,
OCTOBER 2, 2002
THURSDAY,
OCTOBER 3, 2002
Orals Orals Posters Orals Posters Orals Posters Orals Posters

WEDNESDAY, OCTOBER 2, 2002
08:30 - 09:15 Hall A
PLENARY SESSION: INFECTION AND APS
Supported by an unrestricted educational grant from Pharmacia Diagnostics, USA
Chairpersons:
N. Harris, USA
M. Khamashta
, UK
08:30 INFECTIONS, aPL AND APS. A CLINICAL OVERVIEW
R.A. Asherson, South Africa
08:45 THE INFECTIOUS ETIOLOGY OF APS
Y. Shoenfeld, Israel
09:00 EXPLORING THE ORIGINS OF aPL: POSSIBLE INSIGHTS INTO CAUSATION OF AUTOIMMUNE DISEASE
A.E. Gharavi, S.S. Pierangeli, E.N. Harris, USA
 
09:15 - 10:00 Hall A
PATHOGENIC MECHANISMS III
Chairpersons:
S. Machin, UK
B. Brenner
, Israel
09:15 THROMBOGENIC PROPERTIES OF aPL ARE MEDIATED BY E-SELECTIN
X. Liu, R.G. Espinola, M. Colden-Stanfield, E.N. Harris, S.S. Pierangeli, USA
09:25 aPL AND ACQUIRED ACTIVATED PROTEIN C RESISTANCE: RISK FACTORS FOR FETAL LOSS
F. Dawood, R.G. Farquharson, S. Quenby, UK
09:35 ANTI-CD40 ANTIBODIES IN APS
P.G. Vlachoyiannopoulos, C.P. Mavragani, A.V. Balitsari, E. Zintzaras,
J.G. Routsias, H.M. Moutsopoulos, Greece
09:45 DIMERIZATION OF B2GPI IS NECESSARY FOR BINDING TO ENDOTHELIAL CELLS
H.B. De Laat, B.C.H. Lutters, R.H.W.M. Derksen, P.G. De Groot,
The Netherlands
09:55 aPL INHIBITION OF HUMAN ENDOMETRIAL STROMAL CELL DIFFERENTIATION IN VITRO
I.Y.H. Mak R. Rai, J.J. Brosens, M. Christian, F.A. Hills, L. Chamley,
L. Regan, J.O. White, UK
10:00 Coffee Break, Poster Viewing and Exhibition Visit
 
10:30 - 12:40 Hall A
RECURRENT PREGNANCY FAILURE
Supported by an unrestricted educational grant from Pharmacia Diagnostics, USA
Chairpersons:
D.W. Branch, USA
A. Ornoy
, Israel
10:30 aPL AND PREGNANCY LOSS - BEYOND THROMBOSIS
R. Rai, UK
10:50 INDUCTION OF REPRODUCTIVE FAILURE BY ACTIVE IMMUNIZATION WITH LAMININ-1
S. Tartakover-Matalon, M. Blank, E. Matsuura, J. Inagaki, M. Nomizu,
T. Koike, Y. Sherer, A. Ornoy, Y. Shoenfeld, Israel, Japan
11:00 CLINICAL ASSOCIATION OF IGG ANTI-LAMININ-1 AUTOANTIBODIES WITH REPRODUCTIVE FAILURE
J. Inagaki, K. Aoki, T. Koike, Y. Shoenfeld, E. Matsuura, Japan, Israel
11:10 THE EFFECTS OF IgG PURIFIED FROM WOMEN WITH SLE/APS AND ASSOCIATED PREGNANCY LOSS ON RAT EMBRYOS IN-VITRO
A. Ornoy, S. Tartakover-Matalon, S. Yacobi, M. Blank, Z. Blumenfeld,
Y. Shoenfeld, Israel
11:20 MONOCLONAL ANTIBODY AGAINST ANNEXIN V PREVENTS INTERTROPHOBLAST FUSION
N.S. Rote, N. Kumar, S.H. Chang, L. Liln, B. Xu, M.N. Kent, USA
11:40 TYPES OF PREGNANCY LOSS IN aPL RELATED RECURRENT MISCARRIAGE
L. Bricker, R. Farquharson, UK
11:50 THE PREVALENCE AND CLINICAL CONSEQUENCES OF ANTIBODIES TO B2GPI IN THE GENERAL OBSTETRIC POPULATION
T.F. Porter, K. Nelson, M.S. Esplin, R.M. Silver, A. Dowling,
D.W. Branch, USA
12:00 ANTIPHOSPHOLIPID ANTIBODIES IN FOLLICULAR FLUIDS OF IVF-ET PATIENTS
H. Matsubayashi, T. Arai, M. Shida, A. Kondo, S.-I. Izumi, T. Makino, Japan
12:10 PREVALENCE OF ANTI B2GPI ANTIBODIES IN PATIENTS WITH PREGNANCY COMPLICATIONS
D. Faden, S. Zatti, A. Lojacono, L. Barbetti, L. Decca, R. Gorla,
M. Taglietti, M. Frassi, R. Ottaviani, G. Balestrieri, A. Tincani, Italy
12:20 AUTOANTIBODIES PANEL SCREENING AS A TOOL TO PREDICT RECURRENT PREGNANCY LOSS
S.Shai, R.Shabo, G.Fihman, H.Cart,Y.Shoenfeld, Israel
12:30 PREGNANCY OUTCOME: ASSOCIATION WITH ANTI-LAMININ-1 ANTIBODIES IN HUMAN AND IN IMMUNIZED MICE
A. Kondo, S. Tartakover-Matalon, M. Blank, J. Inagaki, K. Kobayashi,
T. Yasuda, K. Aoki, T. Koike, T. Makino, E. Matsuura, Y. Shoenfeld, Japan, Israel
12:40 Lunch Break, Poster Viewing and Exhibition Visit
The International Committee Session:
Decision for the Meetings of 2004 and 2006.
 
14:00 - 16:00 Hall A
ATHEROSCLEROSIS AND APS
Supported by an unrestricted educational grant from INOVA, USA
Chairpersons:
T. Koike, Japan
G. Valesini
, Italy
14:00 INTRODUCTORY COMMENTS: MONOCYTES AND B2GPI
G. Valesini, Italy
14:10 HOPKINS LUPUS COHORT: LESSONS ON ATHEROSCLEROSIS AND HYPERCOAGULABILITY
M. Petri, USA
14:20 ATHEROSCLEROSIS IN PREMENOPAUSAL WOMEN WITH APS AND SLE: A CONTROLLED STUDY
P.G. Vlachoyiannopoulos, P.G. Kanellopoulos, J.P.A. Ioannidis,
M.G. Tektonidou, I. Mastorakou, H.M. Moutsopoulos, Greece
14:30 aPLS AND RECURRENT CORONARY EVENTS AFTER ANGIOPLASTY
H. Kim, A.M. Conti-Kelly, T. Greco, USA
14:40 PREMATURE ATHEROSCLEROSIS IN SUBJECTS WITH IDIOPATHIC aPL
P.R.J. Ames, A. Margarita, J. Delgado Alves, C. Tommasino,
L. Iannaccone, V. Brancaccio, UK, Italy
14:50 SEROLOGICAL AND MORPHOLOGIC FEATURES OF ATHEROSCLEROSIS
Y. Sherer, A. Tenenbaum, M. Blank, E.Z. Fisman, Y. Shoenfeld, Israel
15:00 THE SIGNIFICANCE OF CRP ELEVATIONS IN APS
J. Okada, A. Ishikawa, H. Kondo, Japan
15:10 A NOVEL ELISA FOR OXIDIZED LDL, UTLIZING AN INTERACTION AMONG OXIDIZED LDL, B2GPI, AND B2GPI AUTOANTIBODY
K. Kobayashi, M. Kishi, D. Lopez, Q. Liu, T. Yasuda, T. Koike, L. Lopez,
E. Matsuura, Japan, USA
15:20 ANEURYSMS AND THE APS
A.-M. Piette, P. Graveleau, A. Somogyi, L. Pierot, M. Dupuy, O. Bletry, France
15:30 aCL IS ASSOCIATED WITH DECREASED PARAOXONASE ACTIVITY AND SERUM NITRIC OXIDE IN A MOUSE MODEL
J. Delgado Alves, N.A. Davies, L. Mason, J. Hothersall, C.T. Ravirajan,
D.A. Isenberg, UK
15:40 EVIDENCE OF PARAOXONASE POLYMORPHISM (Gln192Arg) IN PATIENTS WITH APS
M. Lambert, P. Amouyel, F. Martin, E. Hachulla, P.Y. Hatron,
B. Devulder, J.C. Fruchart, P. Duriez, N. Helbecque, France
15:50 ENHANCED TISSUE FACTOR EXPRESSION BY OXIDATIVE STRESS IN PATIENTS WITH aPL
D. Ferro, M. Saliola, P. Meroni, G. Valesini, C. Caroselli, D. Pratico,
G. FitzGerald, S. Yehuda, F. Violi, USA
16:00 Coffee Break, Poster Viewing and Exhibition Visit
 
16:30 - 18:00 Hall A
INFECTIONS AND APS
Supported by an unrestricted educational grant from Aventis, Israel
Chairpersons:
J. Rand, USA
R.A.S. Roubey
, USA
16:30 HIGH LEVELS OF ANTIBODIES TO CYTOMEGALOVIRUS-DERIVED PEPTIDE ARE FOUND IN ANTIPHOSPHOLIPID POSITIVE SERA
A.E. Gharavi, N. Cox, P.A. Romagnoli, R.G. Espinola, E.N. Harris,
S.S. Pierangeli, USA
16:45 BRANCHED PEPTIDES CORRESPONDING TO TARGET EPITOPES ON B2GPI INDUCE APOPTOSIS IN SPECIFIC B CELLS OF PATIENTS WITH APS IN VITRO AND SUPPRESS EXPERIMENTAL APS IN VIVO
M. Blank, Y. Shoenfeld, S. Cabilly, Y. Levi, L. Magrini, J. Heldman,
M. Fridkin, E. Katchalski-Katzir, Israel
17:00 A PEPTIDE THAT SHARES SIMILARITY WITH COMMON BACTERIAL ANTIGENS INHIBITS THROMBOGENIC PROPERTIES OF aPL IN VIVO
S.S. Pierangeli, M. Blank, R.G. Espinola, K. Roye-Green, X. Liu,
E.N. Harris, Y. Shoenfeld, USA, Israel, Jamaica
17:10 DENGUE FEVER RELATED aCL IS TRANSIENT AND NON-B2GPI DEPENDENT
R.A. Levy, D. Oliveira, M. Byrro, S.F. Costa, A. Cersosimo,
E.M.N. Albuquerque, Brazil
17:20 THE INFECTIOUS ORIGIN OF THE APS
M. Blank, I. Krause, M. Fridkin, N. Keller, F. Kvapil, J. Kopolovic,
I. Goldberg, A. Tobar, S. Praprotnik, Y. Shoenfeld, J. Rovensky,
L. Cebecauer, J. Lukac, Israel, Slovakia
17:30 IgG IgM AND IgA aPL IN BLACK AFRICAN INFECTIOUS DISEASE PATIENTS
S. Loizou, S. Singh, E. Wypkema, R.A. Asherson, South Africa,
Greece
17:40 SEVEN aPL IN HIV POSITIVE PATIENTS
Z. Ulcova-Gallova, D. Sedlacek, Czech Republic
17:50
APS - UNSOLVED MYSTERIES
E.N. Harris, S. Pierangeli, A. Gharavi, USA

SUNDAY,
SEPTEMBER 29, 2002
MONDAY,
SEPTEMBER 30, 2002
TUESDAY,
OCTOBER 1, 2002
WEDNESDAY,
OCTOBER 2, 2002
THURSDAY,
OCTOBER 3, 2002
Orals Orals Posters Orals Posters Orals Posters Orals Posters

 
Home | Welcome | Committees | Scientific Program
Timetable | Acknowledgements | Registration
General Information | Accompanying Persons Program
Accommodation & Tours | Optional Congress Tours & Transfers